PREDICTION OF MORTALITY IN SSC-ILD DEPENDS ON DEFINITION OF ILD PROGRESSION

被引：0
|
作者：
Hoffmann-Vold, A. M. [1 ,2 ]
Petelytska, L. [2 ]
Fretheim, H. [1 ]
Barua, I. [1 ]
Becker, M. O.
Bjorkekjaer, H. J. [3 ]
Brunborg, C. [4 ]
Bruni, C. [2 ]
Diep, P. P.
Dobrota, R. [2 ]
Durheim, M. [5 ]
Elhai, M. [2 ]
Jordan, S. [2 ]
Langballe, E. [1 ]
Midtvedt, O. [1 ]
Mihai, C. [2 ]
Molberg, O. [1 ]
Distler, O. [2 ]
机构：
[1] Oslo Univ Hosp, Rheumatol, Oslo, Norway
[2] Univ Zurich, Univ Hosp Zurich, Rheumatol, Zurich, Switzerland
[3] Hosp Southern Norway, Rheumatol, Kristiansand, Norway
[4] Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol, Oslo, Norway
[5] Oslo Univ Hosp, Resp Med, Oslo, Norway
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Lungs; Systemic sclerosis; Prognostic factors;
D O I：
10.1136/annrheumdis-2023-eular.3181
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS1291
引用
收藏
页码：992 / 993
页数：2
相关论文
共 44 条
  • [21] May capillaroscopy be a candidate tool in future algorithms for SSC-ILD: Are we looking for the holy grail? A systematic review
    Smith, Vanessa
    Vanhaecke, Amber
    Guerra, Miguel G.
    Melsens, Karin
    Vandecasteele, Els
    Paolino, Sabrina
    Cutolo, Maurizio
    AUTOIMMUNITY REVIEWS, 2020, 19 (09)
  • [22] KL6 AND IL-18 LEVELS ARE NEGATIVELY CORRELATED WITH RESPIRATORY FUNCTION TESTS AND ILD EXTENT ASSESSED ON HRCT IN PATIENTS WITH SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE (SSC-ILD)
    Sieiro Santos, C.
    Calleja Antolin, S.
    De la Calle Lorenzo, J.
    Lopez Garay, C.
    Moriano, C.
    Bollo de Miguel, E.
    Diez Alvarez, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 990 - 991
  • [23] CONTINUED TREATMENT WITH NINTEDANIB IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD): THREEYEAR DATA FROM SENSCIS-ON
    Allanore, Y.
    Vonk, M.
    Distler, O.
    Azuma, A.
    Mayes, M.
    James, A.
    Kohlbrenner, V.
    Alves, M.
    Khanna, D.
    Highland, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 281 - 281
  • [24] CYCLOPHOSPHAMIDE VS MYCOPHENOLATE MOFETIL IN SCLERODERMA INTERSTITIAL LUNG DISEASE (SSC-ILD) AS INDUCTION THERAPY: A SINGLE CENTER, RETROSPECTIVE ANALYSIS
    Bavliya, M. K.
    Shenoy, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1115 - 1115
  • [25] Fibronectin-EDA accumulates via reduced ubiquitination downstream of Toll-like receptor 9 activation in SSc-ILD fibroblasts
    Tuncer, Ferhan
    Bulik, Melissa
    Villandre, John
    Lear, Travis
    Chen, Yanwen
    Tuncer, Beyza
    Kass, Daniel J.
    Valenzi, Eleanor
    Morse, Christina
    Sembrat, John
    Lafyatis, Robert
    Chen, Bill
    Evankovich, John
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2022, 323 (04) : L484 - L494
  • [26] CD4+LAG3+T cells are decreased in SSc-ILD and affect fibroblast mesenchymal transition by TGF-β3
    Qin, Linmang
    Lin, Haobo
    Zhu, Fu
    Wang, Jieying
    Feng, Tianxiao
    Xu, Ting
    Zhang, Guangfeng
    Zhang, Xiao
    ISCIENCE, 2023, 26 (12)
  • [27] KL6 and IL-18 levels are negatively correlated with respiratory function tests and ILD extent assessed on HRCT in patients with systemic sclerosis-related interstitial lung disease (SSc-ILD)
    Santos, Cristiana Sieiro
    Antolin, Sara Calleja
    Lorenzo, Javier De la Calle
    Garay, Carmen Lopez
    Morales, Clara Moriano
    de Miguel, Elena Bollo
    Guerrero, Miriam Retuerto
    Herranz, Laura Sierra
    Alvarez, Elvira Diez
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 65
  • [28] Cyclophosphamide versus mycophenolate mofetil in scleroderma interstitial lung disease (SSc-ILD) as induction therapy: a single-centre, retrospective analysis
    Shenoy, Padmanabha D.
    Bavaliya, Manish
    Sashidharan, Sujith
    Nalianda, Kaveri
    Sreenath, Sreelakshmi
    ARTHRITIS RESEARCH & THERAPY, 2016, 18
  • [29] ILD PROGRESSION ON STANDARD OF CARE VARIES IN PATIENTS WITH CONNECTIVE TISSUE DISEASE
    Langballe, E.
    Diep, P. P.
    Andersson, H.
    Bruni, C.
    Fretheim, H.
    Garen, T.
    Gunnarsson, R.
    Midtvedt, O.
    Molberg, O.
    Palm, O.
    Reiseter, S.
    Aalokken, T. M.
    Distler, O.
    Hoffmann-Vold, A. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 784 - 785
  • [30] Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD)
    Khedoe, Padmini
    Marges, Emiel
    Hiemstra, Pieter
    Ninaber, Maarten
    Geelhoed, Miranda
    FRONTIERS IN IMMUNOLOGY, 2020, 11
12345